Eli Lilly diabetes drug Mounjaro won UK watchdog backing: Bloomberg Ruchika Sharma8 Sept 2023 7:04 AMBritain: Eli Lilly's drug Mounjaro has won the backing of Britain's drug cost-effectiveness watchdog as a diabetes treatment, Bloomberg News reported...
Submit scientific justification for increasing patients number in study: CDSCO Tells Eli Lilly on Galcanezumab Dr. Divya Colin3 Sept 2023 1:00 PMNew Delhi: In response to the proposal presented by the drug major Eli Lilly for the protocol amendment of the monoclonal antibody Galcanezumab, the...
Europe to face shortage of Eli Lilly diabetes drug Trulicity through September Ruchika Sharma30 Aug 2023 6:00 AMEurope: Europe will continue to face a shortage of Eli Lilly & Co's blockbuster diabetes drug Trulicity through September, the European Medicines...
Retevmo demonstrates superior progression free survival compared to approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer: Eli Lilly Ruchika Sharma23 Aug 2023 7:00 AMRetevmo is a highly selective and potent RET kinase inhibitor with CNS activity.
Boehringer Ingelheim latest to sue US over drug price negotiation plan Ruchika Sharma22 Aug 2023 9:30 AMType 2 diabetes treatment Jardiance, which Boehringer shares with US drugmaker Eli Lilly, is considered among the most likely drugs to be chosen for...
Eli Lilly concludes acquisition of Versanis Bio Ruchika Sharma18 Aug 2023 11:44 AMIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Versanis Bio. The acquisition expands...
Eli Lilly concludes acquisition of Sigilon Therapeutics Ruchika Sharma17 Aug 2023 4:30 AMIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. The acquisition...
Eli Lilly concludes acquisition of DICE Therapeutics Ruchika Sharma12 Aug 2023 9:00 AMIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of DICE Therapeutics, Inc.. The acquisition...
Eli Lilly sued by Nektar Therapeutics over autoimmune disease treatment Ruchika Sharma8 Aug 2023 8:00 AMUS: Nektar Therapeutics has sued Eli Lilly, accusing the U.S. drugmaker of undermining the prospects for a drug the companies were developing...
UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 9:00 AMLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Eli Lilly- Boehringer Ingelheim Jardiance gets European Commission nod to treat adults with CKD Ruchika Sharma26 July 2023 11:00 AMIngelheim: The European Commission (EC) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),...
Eli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference Ruchika Sharma19 July 2023 7:09 AMIndianapolis: Eli Lilly and Company has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly...
